Pharmaron Beijing Expects Up to 10% Rise in H1 Attributable Profit
() -- Pharmaron Beijing (SHE:300759) forecasts a 4% to 10% rise in its net attributable profit to between 729.5 million yuan and 771.5 million yuan in the first half from 701.4 million yuan in the year-ago period, according to a Tuesday filing with the Shenzhen bourse. The drug research company expects earnings per sha